Champions Oncology (CSBR) Accounts Payables (2011 - 2026)

Champions Oncology's Accounts Payables history runs 16 years deep, the most recent figure standing at $5.7 million for Q1 2026.

• In Q1 2026, Accounts Payables rose 12.43% year-over-year to $5.7 million; the TTM figure through Jan 2026 stood at $5.7 million (up 12.43% YoY), while the FY2025 annual figure was $4.2 million, down 26.76% from the prior year.
• Accounts Payables was $5.7 million for Q1 2026 at Champions Oncology, down from $6.0 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $6.0 million in Q4 2025 to a low of $2.5 million in Q3 2022.
• Historically, Accounts Payables has averaged $4.7 million across 5 years, with a median of $4.8 million in 2025.
• The sharpest annual moves came in 2023 and 2025: Accounts Payables soared 127.0% in 2023, then declined 26.76% in 2025.
• A 5-year view of Accounts Payables shows it stood at $4.6 million in 2022, then fell by 1.5% to $4.5 million in 2023, then advanced by 7.01% to $4.9 million in 2024, then rose by 23.47% to $6.0 million in 2025, then decreased by 4.46% to $5.7 million in 2026.
• The last three Accounts Payables figures came in at $5.7 million (Q1 2026), $6.0 million (Q4 2025), and $4.8 million (Q3 2025), per Business Quant data.